FRONTLINE/ CY0200352116 /
2024-07-24 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
272.80NOK | - | 523,390 Turnover: - |
-Bid Size: - | -Ask Size: - | 60.84 bill.NOK | - | - |
GlobeNewswire
07-01
Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase ...
GlobeNewswire
06-26
Kahuna Appoints Vijay Kalvakuntla as Chief Financial Officer to Help Power Next Phase of Growth
GlobeNewswire
06-26
Fortinet Annual Skills Gap Report Reveals Growing Connection Between Cybersecurity Breaches and Skil...
GlobeNewswire
06-26
Incognia Enhances Browser Fingerprint Solution to Protect Enterprises from the Most Destructive Form...
GlobeNewswire
06-25
Frontline Education Releases Research Brief Exploring K-12 Educators’ Perspectives on AI Adoption an...
GlobeNewswire
06-20
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire
06-20
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cem...
GlobeNewswire
06-19
Verizon Frontline connects Utah first responders during search and rescue training
GlobeNewswire
06-18
Kahuna Skills Management Software Enhances Clinical Competency Management for 14,000 Clinicians at M...
GlobeNewswire
06-18
Verizon upgrades network along Jersey Shore to bolster public safety, handle massive data increase
GlobeNewswire
06-18
Verizon gives beach goers a boost with expanded 5G service in Myrtle Beach and Hilton Head, SC
GlobeNewswire
06-18
Frontline Education Launches Absence Community to Support K-12 Schools for Back-to-School Success
GlobeNewswire
06-17
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increa...
GlobeNewswire
06-17
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
GlobeNewswire
06-17
Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Di...
GlobeNewswire
06-14
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Associatio...